Bioscience Daily News Today

HC Wainwright reiterated their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $6.00 price objective on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the stock. Dawson James downgraded shares of Daré […]

Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Several other research analysts have also weighed in on the stock. Dawson James lowered shares of […]

Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. They presently have a $6.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2025 earnings at $0.10 EPS, FY2026 earnings […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 979,200 shares, an increase of 76.8% from the November 30th total of 553,900 shares. Based on an average daily volume of 494,500 shares, the days-to-cover ratio […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.42 and traded as low as $0.33. Daré Bioscience shares last traded at $0.34, with a volume of 233,070 shares changing hands. Analysts Set New Price […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 836,800 shares, a growth of 19.4% from the August 15th total of 700,900 shares. Based on an average daily volume of 307,200 shares, […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.92 and traded as low as $0.62. Daré Bioscience shares last traded at $0.63, with a volume of 280,238 shares trading hands. […]

HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s Q1 2024 earnings at ($0.07) EPS, Q2 2024 earnings at $0.00 EPS, […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – Brookline Capital Management issued their Q3 2023 earnings estimates for Daré Bioscience in a report released on Monday, June 5th. Brookline Capital Management analyst K. Dolliver expects that the biotechnology company will earn ($0.07) per share for the quarter. Brookline Capital Management currently has a “Buy” rating […]

Daré Bioscience (NASDAQ:DARE – Get Rating) and Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Analyst Recommendations This is a breakdown of recent recommendations and […]